2.5700
+0.0200
+(0.78%)
At close: April 17 at 4:00:00 PM EDT
2.5700
0.00
(0.00%)
After hours: April 17 at 4:05:07 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-70,538
-70,538
-59,244
-34,577
-27,151
Investing Cash Flow
29,299
29,299
19,965
-45,859
32,130
Financing Cash Flow
70,080
70,080
14,850
77,229
-2,530
End Cash Position
75,655
75,655
46,814
71,243
74,450
Income Tax Paid Supplemental Data
211
211
248
190
206
Interest Paid Supplemental Data
6,043
6,043
5,940
2,555
2,043
Capital Expenditure
-21
-21
-40
-21
-9
Issuance of Capital Stock
53,547
53,547
14,038
47,765
--
Issuance of Debt
46,772
46,772
--
47,301
--
Repayment of Debt
-50,000
-50,000
--
-17,500
-2,500
Repurchase of Capital Stock
--
--
--
--
-81
Free Cash Flow
-70,559
-70,559
-59,284
-34,598
-27,160
12/31/2021 - 11/17/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
KZR Kezar Life Sciences, Inc.
4.1600
+2.46%
NXTC NextCure, Inc.
0.3612
+7.89%
MIST Milestone Pharmaceuticals Inc.
0.8889
+8.80%
GBIO Generation Bio Co.
0.3921
+13.03%
GRCE Grace Therapeutics, Inc.
2.0900
+2.96%
FENC Fennec Pharmaceuticals Inc.
5.08
-0.39%
IMRN Immuron Limited
1.8929
+11.35%
ABEO Abeona Therapeutics Inc.
4.8400
-0.21%
ACRV Acrivon Therapeutics, Inc.
1.8100
-2.16%
IGMS IGM Biosciences, Inc.
1.2200
+2.52%